Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort (vol 38, pg 2737, 2019)

被引:0
|
作者
Gamboa-Cardenas, Rocio V. [1 ]
Ugarte-Gil, Manuel F. [1 ,2 ]
Massardo, Loreto [3 ]
Sacnun, Monica P. [4 ]
Saurit, Veronica [5 ]
Cardiel, Mario H. [6 ]
Soriano, Enrique R. [7 ]
Pisoni, Cecilia [8 ]
Galarza-Maldonado, Claudio M. [9 ]
Rios, Carlos [10 ]
Radominski, Sebastiao C. [11 ]
Castelar-Pinheiro, Geraldo da R. [12 ]
Bianchi, Washington Alves [13 ]
Appenzeller, Simone [14 ]
da Silveira, Ines Guimaraes [15 ]
de Freitas Zerbini, Cristiano A. [16 ]
Caballero-Uribe, Carlo V. [17 ]
Rojas-Villarraga, Adriana [18 ]
Guibert-Toledano, Marlene [19 ]
Ballesteros, Francisco [20 ]
Montufar, Ruben [21 ]
Vazquez-Mellado, Janitzia [22 ]
Esquivel-Valerio, Jorge [23 ]
De La Torre, Ignacio Garcia [24 ]
Barile-Fabris, Leonor A. [25 ]
Palezuelos, Fedra Irazoque [26 ]
Andrade-Ortega, Lilia [26 ]
Monge, Pablo [27 ]
Teijeiro, Raquel [28 ]
Achurra-Castillo, Angel F. [29 ]
Esteva Spinetti, Maria H. [30 ]
Alarcon, Graciela S. [31 ]
Pons-Estel, Bernardo A. [4 ,32 ]
机构
[1] Hosp Nacl Guillermo Almenara Irigoyen, EsSalud, Serv Reumatol, Ave Miguel Grau 800, Lima 15033, Peru
[2] Univ Cient Sur, Lima, Peru
[3] Univ San Sebastian, Fac Med & Ciencia, Ctr Biol Celular & Biomed CEBICEM, Santiago, Chile
[4] Hosp Prov Rosario, Serv Reumatol, Rosario, Santa Fe, Argentina
[5] Hosp Privado Univ Cordoba, Serv Reumatol, Cordoba, Argentina
[6] Ctr Invest Clin Morelia, Morelia, Michoacan, Mexico
[7] Hosp Italiano Buenos Aires, Serv Clin Med, Secc Reumatol, Buenos Aires, DF, Argentina
[8] Ctr Educ Med Invest Clin Norberto Quirno CEMIC, Secc Inmunol & Reumatol, Buenos Aires, DF, Argentina
[9] Corp Med Monte Sinai, Unidad Enfermedades Reumat & Autoinmunes UNERA, Cuenca, Ecuador
[10] Univ Espiritu Santo, Ctr Reumatol & Rehabil, Guayaquil, Ecuador
[11] Univ Fed Parana, Hosp Clin, Serv Reumatol, Curitiba, Parana, Brazil
[12] Univ Estado Rio de Janeiro, Dept Med Interna, Disciplina Reumatol, Rio De Janeiro, Brazil
[13] Univ Estado Rio de Janeiro, Fac Ciencias Med, Dept Med Interna,Fac Med,Univ Estacio Sa, Serv Reumatol,Hosp Gen Santa Casa Misericordia Ri, Rio De Janeiro, Brazil
[14] Univ Estadual Campinas, Rheumatol Unit, Sch Med Sci, Campinas, SP, Brazil
[15] Pontificia Univ Catolica Rio Grande do Sul, Porto Alegre, RS, Brazil
[16] Ctr Paulista Invest Clin, Sao Paulo, Brazil
[17] Hosp Univ Norte, Serv Reumatol, Barranquilla, Colombia
[18] Fdn Univ Ciencias Salud FUCS, Bogota, Colombia
[19] Hosp Clin Quirurg Diez de Octubre, Serv Reumatol, Havana, Cuba
[20] Hosp Clin San Borja Arriaran, Serv Reumatol, Santiago, Chile
[21] Consultorio Especialidades Inst Salvadoreno Segur, Dept Reumatol, San Salvador, El Salvador
[22] Hosp Gen Mexico City, Serv Reumatol, Mexico City, DF, Mexico
[23] Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Reumatol, Monterrey, Mexico
[24] Univ Guadalajara, Hosp Gen Occidente, Dept Inmunol & Reumatol, Guadalajara, Jalisco, Mexico
[25] Hosp Angeles Pedregal, Serv Reumatol, Mexico City, DF, Mexico
[26] Cto Med Nacl 20 Noviembre, Serv Reumatol, Mexico City, DF, Mexico
[27] Univ Costa Rica, HospitalMexico, Caja Costarricense Seguro Social, San Jose, Costa Rica
[28] MUCAM, Montevideo, Uruguay
[29] Complejo Hosp Metropolitano Dr Arnulfo Arias Madr, Caja Seguro Social Panama, Panama City, Panama
[30] Hosp Cent San Cristobal, Dept Med, Serv Reumatol, San Cristobal, Venezuela
[31] Univ Alabama Birmingham, Sch Med, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL USA
[32] Ctr Reg Enfermedades Autoinmunes & Reumat CREAR, Dept Med Interna, Grp Orono, Rosario, Santa Fe, Argentina
关键词
Early RA outcomes; Early RA remission; Early RA response predictors; Latin America early RA;
D O I
10.1007/s10067-019-04742-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To identify baseline predictors of remission and low disease activity (LDA) in early rheumatoid arthritis (RA) from the GLADAR (Grupo Latino Americano De estudio de la Artritis Reumatoide) cohort. Methods: Patients with 1- and 2-year follow-up visits were included. Remission and LDA were defined by DAS28-ESR (< 2.6 and ≤ 3.2, respectively). Baseline predictors examined were gender, ethnicity, age at diagnosis, socioeconomic status, symptoms’ duration, DMARDs, RF, thrombocytosis, anemia, morning stiffness, DAS28-ESR (and its components), HAQ-DI, DMARDs and corticosteroid use, and Sharp-VDH score. Multivariable binary logistic regression models (excluding DAS28-ESR components to avoid over adjustment) were derived using a backward selection method (α-level set at 0.05). Results: Four hundred ninety-eight patients were included. Remission and LDA/remission were met by 19.3% and 32.5% at the 1-year visit, respectively. For the 280 patients followed for 2 years, these outcomes were met by 24.3% and 38.9%, respectively. Predictors of remission at 1 year were a lower DAS28-ESR (OR 1.17; CI 1.07–1.27; p = 0.001) and HAQ-DI (OR 1.48; CI 1.04–2.10; p = 0.028). At 2 years, only DAS28-ESR (OR 1.40; CI 1.17–1.6; p < 0.001) was a predictor. Predictors of LDA/remission at 1 year were DAS28-ESR (OR 1.42; CI 1.26–1.61; p < 0.001), non-use of corticosteroid (OR 1.74; CI 1.11–2.44; p = 0.008), and male gender (OR 1.77; CI 1.2–2.63; p = 0.036). A lower baseline DAS28-ESR (OR 1.45; CI 1.23–1.70; p < 0.001) was the only predictor of LDA/remission at 2 years. Conclusions: A lower disease activity consistently predicted remission and LDA/remission at 1 and 2 years of follow-up in early RA patients from the GLADAR cohort.Key Points• In patients with early RA, a lower disease activity at first visit is a strong clinical predictor of achieving remission and LDA subsequently.• Other clinical predictors of remission and LDA to keep in mind in these patients are male gender, non-use of corticosteroids and low disability at baseline.• Not using corticosteroids at first visit is associated with a lower disease activity and predicts LDA/remission at 1 year in these patients. © 2019, International League of Associations for Rheumatology (ILAR).
引用
下载
收藏
页码:2963 / 2964
页数:2
相关论文
共 50 条
  • [21] Differences Between Early and Established Rheumatoid Arthritis in Time to Achieving CDAI but Not Fatigue Low Disease Activity and Remission: Data from the OBRI Registry
    Pope, Janet
    Rampakakis, Emmanouil
    Movahedi, Mohammad
    Cesta, Angela
    Sampalis, John
    Bombardier, Claire
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1070 - 1070
  • [22] DIFFERENCES BETWEEN EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS IN TIME TO ACHIEVING CDAI BUT NOT FATIGUE LOW DISEASE ACTIVITY AND REMISSION: DATA FROM THE OBRI REGISTRY
    Pope, J.
    Movahedi, M.
    Rampakakis, E.
    Cesta, A.
    Sampalis, J.
    Bombardier, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 951 - 952
  • [23] Decreased Circulating Visfatin Is Associated with Improved Disease Activity in Early Rheumatoid Arthritis: Data from the PERAC Cohort
    Sglunda, Ondrej
    Mann, Herman
    Hulejova, Hana
    Kuklova, Marketa
    Pecha, Ondrej
    Plestilova, Lenka
    Filkova, Maria
    Pavelka, Karel
    Vencovsky, Jiri
    Senolt, Ladislav
    PLOS ONE, 2014, 9 (07):
  • [24] Synovitis and Tenosynovitis on Ultrasound as Predictors of DMARD Tapering Failure in Patients with Long-Standing Rheumatoid Arthritis in Clinical Remission or Low Disease Activity
    Massignan, Angela
    Mendonca da Silva Chakr, Rafael
    Pamplona Bueno de Andrade, Nicole
    Viegas Brenol, Claiton
    JOURNAL OF ULTRASOUND IN MEDICINE, 2021, 40 (12) : 2549 - 2559
  • [25] Synovitis and Osteitis Are Very Frequent in Rheumatoid Arthritis Clinical Remission: Results from an MRI Study of 294 Patients in Clinical Remission or Low Disease Activity State
    Gandjbakhch, Frederique
    Conaghan, Philip G.
    Ejbjerg, Bo
    Haavardsholm, Espen A.
    Foltz, Violaine
    Brown, Andrew K.
    Dohn, Uffe Moller
    Lassere, Marissa
    Freeston, Jane
    Boyesen, Pernille
    Bird, Paul
    Fautrel, Bruno
    Hetland, Merete Lund
    Emery, Paul
    Bourgeois, Pierre
    Horslev-Petersen, Kim
    Kvien, Tore K.
    McQueen, Fiona
    Ostergaard, Mikkel
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (09) : 2039 - 2044
  • [26] Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL)
    Francisco Ugarte-Gil, Manuel
    Wojdyla, Daniel
    Pons-Estel, Guillermo J.
    Catoggio, Luis J.
    Drenkard, Cristina
    Sarano, Judith
    Berbotto, Guillermo A.
    Borba, Eduardo F.
    Inoue Sato, Emilia
    Tavares Brenol, Joao C.
    Uribe, Oscar
    Ramirez Gomez, Luis A.
    Guibert-Toledano, Marlene
    Massardo, Loreto
    Cardiel, Mario H.
    Silveira, Luis H.
    Chacon-Diaz, Rosa
    Alarcon, Graciela S.
    Pons-Estel, Bernardo A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (12) : 2071 - 2074
  • [27] Predicting Low Disease State and Remission in Early Rheumatoid Arthritis in the First Six Months, Comparing the Simplified Disease Activity Index and European League Against Rheumatism Response Measures: Results From an Early Arthritis Cohort
    Omair, Mohammed A.
    Keystone, Edward
    Bykerk, Vivian
    Lin, Daming
    Xiong, Juan
    Sun, Ye
    Boire, Gilles
    Thorne, J. Carter
    Tin, Diane
    Pope, Janet
    Hitchon, Carol
    Haraoui, Boulos
    Akhavan, Pooneh S.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (05) : 737 - 741
  • [28] SDAI 50 Is More Stringent Than the EULAR Response Measure and a Better Predictor of Low Disease State/Remission in Early Rheumatoid Arthritis: Results from an Early Arthritis Cohort
    Omair, Mohammed
    Keystone, Edward C.
    Bykerk, V. P.
    Haraoui, Boulos
    Boire, Gilles
    Thorne, J. Carter
    Pope, Janet E.
    Lin, Daming
    Hitchon, Carol
    Akhavan, Pooneh S.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [29] Comparison of physical function in early rheumatoid arthritis patients treated with biologics for 1 year who achieved clinical remission or low disease activity
    Hattori, Yosuke
    Kida, Daihei
    Kaneko, Atsushi
    CLINICAL RHEUMATOLOGY, 2017, 36 (11) : 2607 - 2612
  • [30] Comparison of physical function in early rheumatoid arthritis patients treated with biologics for 1 year who achieved clinical remission or low disease activity
    Yosuke Hattori
    Daihei Kida
    Atsushi Kaneko
    Clinical Rheumatology, 2017, 36 : 2607 - 2612